Killing cancer cells by targeted drug-carrying phage nanomedicines

BACKGROUND: Systemic administration of chemotherapeutic agents, in addition to its anti-tumor benefits, results in indiscriminate drug distribution and severe toxicity. This shortcoming may be overcome by targeted drug-carrying platforms that ferry the drug to the tumor site while limiting exposure...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar, Hagit, Yacoby, Iftach, Benhar, Itai
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323368/
https://www.ncbi.nlm.nih.gov/pubmed/18387177
http://dx.doi.org/10.1186/1472-6750-8-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323368/
https://www.ncbi.nlm.nih.gov/pubmed/18387177
http://dx.doi.org/10.1186/1472-6750-8-37

Ejemplares similares